Search - tctmd.com

Displaying 61 - 80 of 89

Sort: Relevancy | Date

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Gary M. Ansel, Michael R. Jaff, Ori Ben-Yehuda

October 11, 2015

Presentation TCT 2015

Is Peripheral Vascular Intervention Cost-effective? If So, From Whose Perspective?

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation ISET 2015

Results of Approved DCB in the United States

Presenter: Gary M. Ansel

February 01, 2015

Presentation VEINS 2014

Characteristics of the Optimal Venous Stent

Presenter: Gary M. Ansel

October 11, 2014

News Industry News

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

September 16, 2014

Presentation TCT 2014

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Marianne Brodmann

September 15, 2014

Presentation TCT 2014

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia

September 15, 2014

Presentation TCT 2014

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Peter A. Schneider

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gary M. Ansel

September 15, 2014

News Daily News

EVAR对患者安全性优于AAA手术

L.A. McKeown

July 17, 2014

News Daily News

EVAR Results in Higher Patient-Level Safety Benefit than Surgery for AAA

L.A. McKeown

July 17, 2014

News Daily News

EVAR Ofrece a los Pacientes una Mayor Seguridad que la Cirugía en Casos de AAA

L.A. McKeown

July 17, 2014

Presentation TCT 2013

Evolution in AAA Endograft Devices, Technique, and Outcomes

Presenter: Gary Ansel

October 30, 2013

Presentation TCT 2013

Nonsense: Get It Open, Heal the Wound, and Move On!

Presenter: Gary Ansel

October 28, 2013

News Industry News

Cardiovascular Systems Enrolls First Patient in Liberty 360° Study

May 31, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

April 12, 2013

News Industry News

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease

November 14, 2012

Presentation TCT 2012

SFA Intervention: State of the Art Today and in 2020

Presenter: Gary Ansel

October 24, 2012

Presentation TCT 2012

Update on Important SFA Therapies: VIBRANT, VIPER and Zilver PTX Studies

Presenter: Gary Ansel

October 22, 2012

Advertisement

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Is Peripheral Vascular Intervention Cost-effective? If So, From Whose Perspective?

Results of Approved DCB in the United States

Characteristics of the Optimal Venous Stent

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

EVAR对患者安全性优于AAA手术

EVAR Results in Higher Patient-Level Safety Benefit than Surgery for AAA

EVAR Ofrece a los Pacientes una Mayor Seguridad que la Cirugía en Casos de AAA

Evolution in AAA Endograft Devices, Technique, and Outcomes

Nonsense: Get It Open, Heal the Wound, and Move On!

Cardiovascular Systems Enrolls First Patient in Liberty 360° Study

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease

SFA Intervention: State of the Art Today and in 2020

Update on Important SFA Therapies: VIBRANT, VIPER and Zilver PTX Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content